Overview
IMUNOR® Preparation in the Prevention of COVID-19
Status:
Completed
Completed
Trial end date:
2021-06-02
2021-06-02
Target enrollment:
0
0
Participant gender:
All
All
Summary
The aim of the study is to achieve prevention of COVID-19 disease in healthcare professionals with the administration of the IMUNOR® preparation, and decreasing the symptoms should the disease appear.Phase:
Phase 4Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
University Hospital Ostrava
Criteria
Inclusion Criteria:- Study subjects 18-60 years old
- Ability to cooperate upon the study and to give informed consent
Exclusion Criteria:
- Use of any other immunomodulation treatment one month prior to enrolment and in the
course of the study
- Acute disease of the cardiovascular, urogenital, respiratory or nervous system